BioSpace News Archive

Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services

The company, states growth is being predominantly driven by biotech partners with innovative products, particularly those in the United States where outsourcing demand is growing quickly.

November 5, 2021
·
3 min read
Pharm Country

atai Life Sciences to Participate in Upcoming November Investor Conferences

atai Life Sciences N.V. today announced that it will participate in the following upcoming investor conferences in November:

November 5, 2021
·
2 min read
Business

Provention Bio Appoints Miguel Sanjuan, Ph.D. as Senior Vice President of Research and Early Development

Provention Bio, Inc. today announced the appointment of Miguel Sanjuan , Ph.D. as Senior Vice President of Research and Early Development.

November 5, 2021
·
5 min read
Deals

U.S. SEC Issues Order Declaring Allarity Therapeutics Inc.’s Form S-4 Registration Statement Effective Ahead of Planned Transition to U.S. Nasdaq

An application for listing on the U.S. Nasdaq Stock Market for the shares of Allarity Therapeutics, Inc. (Delaware) (Nasdaq: ALLR) has been made conditioned upon shareholder approval of the Company’s Recapitalization Share Exchange

November 5, 2021
·
10 min read
ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th Annual Evercore ISI HealthCONx Conference

ICON plc today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at: the 30th Annual Credit Suisse Healthcare Conference on Tuesday, November 9, 2021 at 8.50am ET

November 5, 2021
·
2 min read
SiSaf exercises its option under licencing agreement on gene therapy for rare bone disease and announces progress on IND enabling studies

SiSaf Ltd, a company developing RNA therapeutics for rare genetic skeletal disorders, today announced that it has exercised its option under its collaboration with the University of L’Aquila, Italy.

November 5, 2021
·
6 min read
Biotech Bay

MYNZ Closes Its First Day of Trading on the Nasdaq Capital Market

Mainz Biomed N.V., a molecular genetics diagnostics company specializing in the early detection of cancer, announced that its common stock commenced trading on the Nasdaq Capital Market today under the ticker symbol MYNZ.

November 5, 2021
·
3 min read
UPDATE – Galectin Therapeutics to Present Six Scientific Abstracts at The Liver Meeting™ 2021, Hosted by the AASLD

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that it will present six scientific abstracts at The Liver Meeting™ 2021

November 5, 2021
·
10 min read
Biotech Bay

Titan Announces Upcoming TP-2021 Implant Data Presentation at Neuroscience 2021

Titan Pharmaceuticals, Inc. announced that data from continuing studies of its ProNeura ® -based TP-2021 implant in an established animal model of chronic pruritus will be presented at the Society for Neuroscience 2021 Meeting, being held virtually, on November 8 .

November 5, 2021
·
2 min read
Genetown

ReWalk Robotics to Hold its Third Quarter 2021 Earnings Call on November 11, 2021

ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that management will hold its third quarter 2021 earnings call Thursday, November 11, 2021, at 8:30 AM Eastern time.

November 5, 2021
·
1 min read